8-142912850-A-G
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000498.3(CYP11B2):c.1157T>C(p.Val386Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.107 in 1,597,830 control chromosomes in the GnomAD database, including 10,505 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Synonymous variant affecting the same amino acid position (i.e. V386V) has been classified as Likely benign.
Frequency
Consequence
NM_000498.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000498.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CYP11B2 | NM_000498.3 | MANE Select | c.1157T>C | p.Val386Ala | missense | Exon 7 of 9 | NP_000489.3 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CYP11B2 | ENST00000323110.2 | TSL:1 MANE Select | c.1157T>C | p.Val386Ala | missense | Exon 7 of 9 | ENSP00000325822.2 | ||
| GML | ENST00000522728.5 | TSL:3 | c.182-1113A>G | intron | N/A | ENSP00000430799.1 |
Frequencies
GnomAD3 genomes AF: 0.0883 AC: 13358AN: 151294Hom.: 711 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0845 AC: 20671AN: 244568 AF XY: 0.0885 show subpopulations
GnomAD4 exome AF: 0.108 AC: 156905AN: 1446418Hom.: 9792 Cov.: 44 AF XY: 0.110 AC XY: 78858AN XY: 719516 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome AF: 0.0883 AC: 13365AN: 151412Hom.: 713 Cov.: 32 AF XY: 0.0867 AC XY: 6415AN XY: 73996 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3
This variant is associated with the following publications: (PMID: 20981092, 9703385, 27125267, 21237269, 1594605, 11174838, 22465514, 22995991, 10965212, 27884173, 7485152, 28190867, 16733366, 9814506, 30864636)
Corticosterone methyloxidase type 2 deficiency Benign:2Other:1
Variant interpretted as Pathogenic and reported on 05-03-2012 by Lab or GTR ID 504843. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign.
Corticosterone 18-monooxygenase deficiency Benign:2
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign.
Corticosterone 18-monooxygenase deficiency;C3463917:Corticosterone methyloxidase type 2 deficiency Benign:1
Glucocorticoid-remediable aldosteronism Benign:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at